journal article·2010-03

Chondrogenesis of human mesenchymal stem cells encapsulated in a hydrogel construct: Neocartilage formation in animal models as both mice and rabbits

Ji Sun Park, Dae Gyun Woo, Han Na Yang, Hye Jin Lim, Kyong Mi Park, Kun Na, Keun‐Hong Park

Publisher page

Abstract

Abstract In this study, in vivo studies, both nude mouse and rabbit cartilage defect, were tested for chondrogenesis using stem cells (SCs) using growth factor. Specifically, human mesenchymal stem cells (hMSCs) were embedded in a hydrogel scaffold, which was coencapsulated with transforming growth factor‐β3 (TGF‐β3). The specific extracellular matrices (ECMs) released from hMSCs transplanted into the animal were assessed via glycosaminoglycan (GAG)/DNA content, RT‐PCR, real time‐QPCR, immunohistochemical (IHC), and Safranin‐O staining and were observed up to 7 weeks after injection. By detection of ECMs the GAG content per cell remained constant for all formulations, indicating that the dramatic increase in cell number for samples with TGF‐β3 was accompanied by the maintenance of the cell phenotypes. The histological and IHC staining of the newly repaired tissues observed after treatment with TGF‐β3 mixed with hMSCs evidenced hyaline cartilage‐like characteristics. Moreover, the results observed with the animal model (rabbit) treated with hMSCs embedded in the growth factor‐containing hydrogel indicate that the implantation of mixed cells with TGF‐β3 may constitute a clinically efficient method for the regeneration of hyaline articular cartilage. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Knee injuries and reconstruction techniques · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. 10.1517/14712598.6.5.48510.1517/14712598.6.5.485 ↗
2. 10.1016/j.biomaterials.2006.02.04810.1016/j.biomaterials.2006.02.048 ↗
3. 10.1016/j.biomaterials.2005.11.01510.1016/j.biomaterials.2005.11.015 ↗
4. 10.1089/ten.2006.12.50910.1089/ten.2006.12.509 ↗
5. 10.1089/ten.2005.11.121210.1089/ten.2005.11.1212 ↗
6. 10.1016/j.biomaterials.2005.03.03810.1016/j.biomaterials.2005.03.038 ↗
7. 10.1016/j.biomaterials.2004.04.02910.1016/j.biomaterials.2004.04.029 ↗
8. 10.1016/j.biomaterials.2005.01.00210.1016/j.biomaterials.2005.01.002 ↗
9. 10.1016/j.biomaterials.2004.03.00510.1016/j.biomaterials.2004.03.005 ↗
10. 10.1016/j.biomaterials.2005.05.02210.1016/j.biomaterials.2005.05.022 ↗
11. 10.1016/S1471-4914(01)02016-010.1016/S1471-4914(01)02016-0 ↗
12. 10.1016/j.joca.2005.09.00210.1016/j.joca.2005.09.002 ↗
13. 10.1016/j.cardiores.2006.12.01210.1016/j.cardiores.2006.12.012 ↗
14. 10.1359/jbmr.05121310.1359/jbmr.051213 ↗
15. 10.1002/jbm.a.3014810.1002/jbm.a.30148 ↗
16. 10.1016/j.biomaterials.2004.01.05110.1016/j.biomaterials.2004.01.051 ↗
17. Encapsulating chondrocytes in degrading PEG hydrogels with high modulus: Engineering gel structural changes to facilitate cartilaginous tissue production
18. 10.1073/pnas.14230999910.1073/pnas.142309999 ↗
19. 10.1002/jbm.a.3045210.1002/jbm.a.30452 ↗
20. 10.1097/00000637-199804000-0001610.1097/00000637-199804000-00016 ↗
21. 10.1053/joca.2000.037310.1053/joca.2000.0373 ↗
22. 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L ↗
23. 10.1016/j.biomaterials.2005.06.03710.1016/j.biomaterials.2005.06.037 ↗
24. 10.1007/s10529-005-8453-010.1007/s10529-005-8453-0 ↗
25. 10.1002/jbm.122510.1002/jbm.1225 ↗
26. 10.1016/j.biomaterials.2006.08.01210.1016/j.biomaterials.2006.08.012 ↗
27. 10.1089/ten.2005.11.119810.1089/ten.2005.11.1198 ↗
28. 10.1016/j.jconrel.2007.04.01610.1016/j.jconrel.2007.04.016 ↗
29. 10.1002/jbm.a.3125510.1002/jbm.a.31255 ↗
30. 10.1002/art.2156110.1002/art.21561 ↗